FDA Approves Zilganersen, First Treatment for Alexander Disease
FDA Approves Zilganersen, First Treatment for Alexander Disease Neurology Live
Finance, IT & News
FDA Approves Zilganersen, First Treatment for Alexander Disease Neurology Live
Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder STAT
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the…
The U.S. Food and Drug Administration has approved Zanvastro (zilganersen) injection for the treatment of Alexander disease in pediatric and…
Fitch Maintains Deteriorating Outlook for Global Reinsurance for 2027 marketscreener.com